- Home
- ALIS vs ECOR Comparison
ALIS vs ECOR Comparison
Compare ALIS & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALIS | ECOR |
|---|---|---|
| Founded | 2024 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.9M | 81.0M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALIS | ECOR |
|---|---|---|
| Price | $10.21 | $10.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 46.5K | ★ 80.7K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $255.25 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $9.87 | $4.41 |
| 52 Week High | $10.25 | $10.93 |
Technical Indicators
Market Signals| Indicator | ALIS | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 66.53 | 65.99 |
| Support Level | $10.05 | $5.17 |
| Resistance Level | N/A | $10.13 |
| Average True Range (ATR) | 0.01 | 0.96 |
| MACD | 0.00 | 0.33 |
| Stochastic Oscillator | 60.00 | 80.35 |
Price Performance
Historical ComparisonAbout ALIS Calisa Acquisition Corp Ordinary shares
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.